Clinical outcomes in stage III non-small cell lung cancer patients treated with durvalumab after sequential or concurrent platinum-based chemoradiotherapy – single institute experience. Radiol Oncol [Internet]. 2021 Dec. 20 [cited 2026 Sep. 20];55(4):482-90. Available from: https://radioloncol.com/index.php/ro/article/view/3757